News Diseases JN.1 New COVID-19 variant: Spreading rapidly By Editor's Desk 23 December 2023 JN.1 New Covid-19 variant: Spreading rapidly CDC says that there is no current risk to the health from the spreading variants
Regulatory Approval Healthcare & Pharmaceuticals News Oncology AstraZeneca’s Enhertu EU Approval: Enhertu Plus Pertuzumab Cleared as First-Line Therapy for HER2-Positive Metastatic Breast Cancer 1 September 20262 September 2026 Regulatory Intelligence Desk
Merger & Acquisitions Business Healthcare & Pharmaceuticals News Lilly Merida Biosciences Acquisition: Eli Lilly to Pay $2.875 Billion for Precision Autoantibody Therapies 31 August 20261 September 2026 BiotechReality Business Intelligence Desk
Clinical Data Healthcare & Pharmaceuticals News Roche Vabysmo PCV Study Shows Sustained Two-Year Results in Difficult-to-Treat nAMD Subtype 28 August 202628 August 2026 Clinical Trials & Data Desk
Clinical Data Healthcare & Pharmaceuticals News TEZSPIRE Eosinophilic Esophagitis Trial: Amgen, AstraZeneca Report Positive Phase 3 CROSSING Results 27 August 202628 August 2026 Clinical Trials & Data Desk
Technology Diabetes Healthcare & Pharmaceuticals News Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor 26 August 202626 August 2026 Regulatory Intelligence Desk
Healthcare & Pharmaceuticals Autoimmune Diseases News Regulatory Approval Johnson & Johnson’s IMAAVY Nipocalimab-aahu Wins FDA Approval as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia 25 August 202625 August 2026 Regulatory Intelligence Desk